<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="63756">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01889537</url>
  </required_header>
  <id_info>
    <org_study_id>43329-K</org_study_id>
    <nct_id>NCT01889537</nct_id>
  </id_info>
  <brief_title>Low Dose Ketamine VR Analgesia During Burn Care Procedure</brief_title>
  <acronym>VRK</acronym>
  <official_title>Low Dose Ketamine to Enhance VR Analgesia During Painful Burn Care Procedure.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of General Medical Sciences (NIGMS)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institute of General Medical Sciences (NIGMS)</source>
  <oversight_info>
    <authority>United States: Federal Government</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the research is to see whether a low dose of ketamine, a medication used to
      reduce pain, enhances the effectiveness of a virtual reality video game, which is used as a
      form of distraction from pain during a painful burn care procedure.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">April 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research</study_design>
  <primary_outcome>
    <measure>Graphic Rating Scale (GRS) is a questionnaire consists of three subjective pain ratings, one subjective anxiety rating, and one rating of fun using the 0-10.</measure>
    <time_frame>1 day (Immediately following burn care )</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Burn</condition>
  <arm_group>
    <arm_group_label>VR during burn care with Ketamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Comparing Virtual Reality during burn care with Ketamine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VR durin burn care without Ketamine</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Comparing virtual reality during burn care without Ketamine.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Virtual Reality</intervention_name>
    <arm_group_label>VR during burn care with Ketamine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age greater than or equal to 18 years

          -  Compliant and able to complete questionnaires

          -  No history of psychiatric disorder

          -  Not demonstrating delirium, psychosis or any form of Organic Brain Disorder

          -  Able to communicate verbally

          -  English-speaking

          -  IV access already in place

        Exclusion Criteria:

          -  Age less than 18 years

          -  Not capable of indicating pain intensity

          -  Not capable of filling out study measures

          -  Evidence of traumatic brain injury

          -  History of psychiatric disorder

          -  Demonstrating delirium, psychosis or any form of Organic Brain Disorder and
             associated memory problems

          -  Unable to communicate orally

          -  Receiving prophylaxis for alcohol or drug withdrawal

          -  Developmental disability

          -  Any face/head/neck injuries that interfere with the use of Virtual Reality equipment

          -  Non-English Speaking

          -  Extreme susceptibility to motion sickness

          -  Seizure history

          -  No IV access already in place
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David R Patterson, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Washington</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David R Patterson, Ph.D.</last_name>
    <phone>206-744-5443</phone>
    <email>davepatt@uw.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maryam Soltani, M.Ed.</last_name>
    <phone>206-744-2172</phone>
    <email>soltani@uw.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Harborview Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Patterson, PH.D.</last_name>
      <phone>206-744-3418</phone>
      <email>davepatt@uw.edu</email>
    </contact>
    <investigator>
      <last_name>David Patterson, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>September 30, 2013</lastchanged_date>
  <firstreceived_date>May 6, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Institute of General Medical Sciences (NIGMS)</investigator_affiliation>
    <investigator_full_name>David R. Patterson</investigator_full_name>
    <investigator_title>PhD. ABPP, Professor</investigator_title>
  </responsible_party>
  <keyword>Virtual Reality Ketamine</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Burns</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
